Twilight fund fades away: Meanwhile, six BioCrossroads-backed VCs are just getting started
Its specialty is developing local life sciences startups. But its partners can’t raise any more money. So the sun is setting on Twilight Venture Partners. Meanwhile, the six venture capital firms BioCrossroads staked with its $73 million Indiana Future Fund have just three local investments to show among them. Venture investments take time, the six IFF recipients argue. And their first duty is to earn the high rate of return the IFF’s organizers demand. That means significant proof of concept…